These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 29471464)

  • 21. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results.
    Andrews N; McMenamin J; Durnall H; Ellis J; Lackenby A; Robertson C; von Wissmann B; Cottrell S; Smyth B; Moore C; Gunson R; Zambon M; Fleming D; Pebody R
    Euro Surveill; 2014 Jul; 19(27):5-13. PubMed ID: 25033051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic and antigenic characterization of hemagglutinin of influenza A/H3N2 virus from the 2015 season in Thailand.
    Tewawong N; Suntronwong N; Vichiwattana P; Vongpunsawad S; Theamboonlers A; Poovorawan Y
    Virus Genes; 2016 Oct; 52(5):711-5. PubMed ID: 27146171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Directed selection of influenza virus produces antigenic variants that match circulating human virus isolates and escape from vaccine-mediated immune protection.
    DeDiego ML; Anderson CS; Yang H; Holden-Wiltse J; Fitzgerald T; Treanor JJ; Topham DJ
    Immunology; 2016 Jun; 148(2):160-73. PubMed ID: 26854888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influenza Vaccine Effectiveness by A(H3N2) Phylogenetic Subcluster and Prior Vaccination History: 2016-2017 and 2017-2018 Epidemics in Canada.
    Skowronski DM; Leir S; Sabaiduc S; Chambers C; Zou M; Rose C; Olsha R; Dickinson JA; Winter AL; Jassem A; Gubbay JB; Drews SJ; Charest H; Chan T; Hickman R; Bastien N; Li Y; Krajden M; De Serres G
    J Infect Dis; 2022 Apr; 225(8):1387-1398. PubMed ID: 32215564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of seasonal influenza vaccine in Australia, 2015: An epidemiological, antigenic and phylogenetic assessment.
    Fielding JE; Levy A; Chilver MB; Deng YM; Regan AK; Grant KA; Stocks NP; Sullivan SG
    Vaccine; 2016 Sep; 34(41):4905-4912. PubMed ID: 27577556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.
    Skowronski DM; Masaro C; Kwindt TL; Mak A; Petric M; Li Y; Sebastian R; Chong M; Tam T; De Serres G
    Vaccine; 2007 Apr; 25(15):2842-51. PubMed ID: 17081662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic and antigenic divergence in the influenza A(H3N2) virus circulating between 2016 and 2017 in Thailand.
    Suntronwong N; Klinfueng S; Vichiwattana P; Korkong S; Thongmee T; Vongpunsawad S; Poovorawan Y
    PLoS One; 2017; 12(12):e0189511. PubMed ID: 29252990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of A(H3N2) Neutralizing Antibody Responses Elicited by 2018-2019 Season Quadrivalent Influenza Vaccines Derived from Eggs, Cells, and Recombinant Hemagglutinin.
    Wang W; Alvarado-Facundo E; Vassell R; Collins L; Colombo RE; Ganesan A; Geaney C; Hrncir D; Lalani T; Markelz AE; Maves RC; McClenathan B; Mende K; Richard SA; Schofield C; Seshadri S; Spooner C; Utz GC; Warkentien TE; Levine M; Coles CL; Burgess TH; Eichelberger M; Weiss CD
    Clin Infect Dis; 2021 Dec; 73(11):e4312-e4320. PubMed ID: 32898271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imprinting of Repeated Influenza A/H3 Exposures on Antibody Quantity and Antibody Quality: Implications for Seasonal Vaccine Strain Selection and Vaccine Performance.
    Kosikova M; Li L; Radvak P; Ye Z; Wan XF; Xie H
    Clin Infect Dis; 2018 Oct; 67(10):1523-1532. PubMed ID: 29672713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Household Influenza Vaccine Effectiveness Study: Lack of Antibody Response and Protection Following Receipt of 2014-2015 Influenza Vaccine.
    Petrie JG; Malosh RE; Cheng CK; Ohmit SE; Martin ET; Johnson E; Truscon R; Eichelberger MC; Gubareva LV; Fry AM; Monto AS
    Clin Infect Dis; 2017 Oct; 65(10):1644-1651. PubMed ID: 29020179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-specific effects of vaccine egg adaptation and immune priming on A(H3N2) antibody responses following influenza vaccination.
    Liu F; Gross FL; Jefferson SN; Holiday C; Bai Y; Wang L; Zhou B; Levine MZ
    J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33690218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ιnfluenza A(H3N2) genetic variants in vaccinated patients in northern Greece.
    Melidou A; Gioula G; Exindari M; Ioannou E; Gkolfinopoulou K; Georgakopoulou T; Tsiodras S; Papa A
    J Clin Virol; 2017 Sep; 94():29-32. PubMed ID: 28734139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
    J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):393-8. PubMed ID: 18418344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A(H3N2) antigenic variation of influenza is associated with low vaccine efficacy in the early 2018 influenza season in Mexico City.
    Hernández-Hernández VA; Higuera-Iglesias AL; Palma-Cortes G; Tapia-Trejo D; Ávila-Ríos S; González-Fernández RR; Pérez-Moreno LÁ; Zuñiga-Ramos JA; Guadarrama-Pérez C; Sandoval-Gutiérrez JL; Cabello-Gutiérrez C
    Int J Infect Dis; 2022 Dec; 125():114-119. PubMed ID: 36283676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly.
    de Jong JC; Beyer WE; Palache AM; Rimmelzwaan GF; Osterhaus AD
    J Med Virol; 2000 May; 61(1):94-9. PubMed ID: 10745239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of seasonal vaccination on the selection of influenza A/H3N2 epidemic variants.
    Chong Y; Ikematsu H
    Vaccine; 2017 Jan; 35(2):255-263. PubMed ID: 27919631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 2015-2016 influenza epidemic in Beijing, China: Unlike elsewhere, circulation of influenza A(H3N2) with moderate vaccine effectiveness.
    Zhang L; Pan Y; Hackert V; van der Hoek W; Meijer A; Krafft T; Yang P; Wang Q
    Vaccine; 2018 Aug; 36(33):4993-5001. PubMed ID: 30017144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partial Protection Induced by 2011-2012 Influenza Vaccine Against Serologically Evidenced A(H3N2) Influenza Virus Infections in Elderly Institutionalized People.
    Camilloni B; Basileo M; Menculini G; Tozzi P; Iorio AM
    Adv Exp Med Biol; 2016; 897():45-53. PubMed ID: 26577530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low Influenza Vaccine Effectiveness Against A(H3N2)-Associated Hospitalizations in 2016-2017 and 2017-2018 of the Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).
    Martin ET; Cheng C; Petrie JG; Alyanak E; Gaglani M; Middleton DB; Ghamande S; Silveira FP; Murthy K; Zimmerman RK; Monto AS; Trabue C; Talbot HK; Ferdinands JM;
    J Infect Dis; 2021 Jun; 223(12):2062-2071. PubMed ID: 33140094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.